(AMN) AMN Healthcare - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0017441017

Nurse Staffing, Physician Staffing, Technology

AMN EPS (Earnings per Share)

EPS (Earnings per Share) of AMN over the last years for every Quarter: "2020-03": 0.27, "2020-06": 0.47, "2020-09": 0.55, "2020-12": 0.19, "2021-03": 1.47, "2021-06": 1.39, "2021-09": 1.54, "2021-12": 2.42, "2022-03": 3.09, "2022-06": 2.77, "2022-09": 2.1, "2022-12": 1.88, "2023-03": 2.02, "2023-06": 1.55, "2023-09": 1.39, "2023-12": 0.33, "2024-03": 0.45, "2024-06": 0.42, "2024-09": 0.18, "2024-12": -4.9, "2025-03": -0.03,

AMN Revenue

Revenue of AMN over the last years for every Quarter: 2020-03: 602.461, 2020-06: 608.351, 2020-09: 551.631, 2020-12: 631.271, 2021-03: 885.945, 2021-06: 857.445, 2021-09: 877.8, 2021-12: 1363.045, 2022-03: 1552.538, 2022-06: 1426.607, 2022-09: 1138.586, 2022-12: 1125.511, 2023-03: 1126.223, 2023-06: 991.299, 2023-09: 853.463, 2023-12: 818.269, 2024-03: 820.878, 2024-06: 740.685, 2024-09: 687.509, 2024-12: 734.709, 2025-03: 689.533,

Description: AMN AMN Healthcare

AMN Healthcare Services, Inc. is a leading provider of technology-enabled healthcare workforce solutions and staffing services in the United States, catering to acute and sub-acute care hospitals, and other healthcare facilities. The companys comprehensive suite of services is delivered through three primary segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.

The Nurse and Allied Solutions segment is a major contributor, offering a range of staffing services including travel nurse staffing, local staffing, and allied staffing, as well as permanent placement solutions for international nurses and allied health professionals. Additionally, this segment provides specialized services such as crisis nurse staffing and teletherapy platforms, addressing the diverse needs of healthcare facilities, schools, and other organizations.

The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions, while the Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions, further enhancing the companys capabilities.

AMN Healthcare Services operates under multiple brands, including AMN Healthcare, Nursefinders, and OGrady Peyton International, among others, allowing the company to maintain a strong presence in the market. With its founding in 1985 and headquarters in Dallas, Texas, the company has established itself as a key player in the healthcare staffing industry.

From a technical analysis perspective, AMNs stock has shown a recent price of $21.91, with its 20-day SMA at $21.30 and 50-day SMA at $20.68, indicating a potential upward trend. However, the 200-day SMA stands at $28.25, suggesting a longer-term downtrend. The ATR of 0.92 represents a 4.21% daily volatility, and the stocks 52-week high and low are $68.05 and $17.79, respectively.

Fundamentally, AMN Healthcare Services has a market capitalization of $853.79M USD and a forward P/E ratio of 24.75, indicating a relatively high valuation. The companys return on equity is currently negative at -20.74, which may raise concerns about its profitability.

Forecast: Based on the technical and fundamental data, a potential forecast for AMN Healthcare Services could be a short-term price increase, driven by the recent upward trend and the stocks proximity to its 20-day and 50-day SMAs. However, the long-term downtrend indicated by the 200-day SMA and the negative RoE may pose a risk to the stocks sustainability. As such, a cautious approach may be warranted, with a potential entry point around $20.50-$21.00, and a stop-loss below $20.00. A reversion to its 52-week high is unlikely in the short term, and the stock may continue to consolidate around its current price levels.

Additional Sources for AMN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AMN Stock Overview

Market Cap in USD 837m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2001-11-13

AMN Stock Ratings

Growth Rating -64.0
Fundamental -37.2
Dividend Rating 0.0
Rel. Strength -52.6
Analysts 3.33 of 5
Fair Price Momentum 18.42 USD
Fair Price DCF 142.04 USD

AMN Dividends

Currently no dividends paid

AMN Growth Ratios

Growth Correlation 3m 57.7%
Growth Correlation 12m -92.4%
Growth Correlation 5y -47.9%
CAGR 5y -12.98%
CAGR/Max DD 5y -0.15
Sharpe Ratio 12m -1.39
Alpha -60.58
Beta 0.076
Volatility 49.03%
Current Volume 367.6k
Average Volume 20d 623k
What is the price of AMN shares?
As of July 06, 2025, the stock is trading at USD 21.92 with a total of 367,600 shares traded.
Over the past week, the price has changed by +4.98%, over one month by +9.33%, over three months by +7.56% and over the past year by -54.77%.
Is AMN Healthcare a good stock to buy?
Probably not. Based on ValueRay´s Fundamental Analyses, AMN Healthcare (NYSE:AMN) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.19 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMN is around 18.42 USD . This means that AMN is currently overvalued and has a potential downside of -15.97%.
Is AMN a buy, sell or hold?
AMN Healthcare has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AMN.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
What are the forecasts for AMN share price target?
According to our own proprietary Forecast Model, AMN AMN Healthcare will be worth about 19.9 in July 2026. The stock is currently trading at 21.92. This means that the stock has a potential downside of -9.26%.
Issuer Target Up/Down from current
Wallstreet Target Price 26.5 21.1%
Analysts Target Price 26.5 21.1%
ValueRay Target Price 19.9 -9.3%